Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Hesperin is a bioactive ingredient present in Japanese horseradish (wasabi). It has been shown to be an activator of Nrf2.
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 560 | 35日内发货 | ||
5 mg | ¥ 2,130 | 35日内发货 | ||
10 mg | ¥ 3,220 | 35日内发货 | ||
25 mg | ¥ 3,940 | 35日内发货 |
产品描述 | Hesperin is a bioactive ingredient present in Japanese horseradish (wasabi). It has been shown to be an activator of Nrf2. |
体外活性 | Hesperin is an active compound in wasabi. Whether Hesperin causes cytotoxicity of HUVECs is determined. To study the anti-coagulant and anti-inflammatory properties of Hesperin in HUVECs, in subsequent experiments we used Hesperin is used at concentrations of 0-1 μg/mL. More than 1 μg/mL of Hesperin markedly causes cytotoxicity and morphological alterations[2]. |
体内活性 | Wild-type and Nrf2-null mice are fed the following diets for 12 weeks : 1) control diet, 2) high-fat diet (HFD), 3) HFD plus Hesperin (10 mg/kg/day ip), 4) HFD for 6 weeks followed by an iron-supplemented HFD for 6 weeks (HFD/Iron), 5) HFD/Iron plus Hesperin to determine whether Hesperin ameliorates hepatic steatosis and iron accumulation. Hesperin activates Nrf2 and causes phase II enzyme genes but this induction is absent in Nrf2-null mice, showing that Hesperin is a potential activator of the Nrf2/ARE-dependent detoxification pathway. The HFD enhanced hepatic triglycerides in both genotypes and Hesperin suppress increased hepatic triglycerides in wild-type mice but does not reduce these triglycerides in Nrf2-null mice[1]. |
分子量 | 205.34 |
分子式 | C8H15NOS2 |
CAS No. | 4430-35-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (243.50 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 4.87 mL | 24.3499 mL | 48.6997 mL | 121.7493 mL |
5 mM | 0.974 mL | 4.87 mL | 9.7399 mL | 24.3499 mL | |
10 mM | 0.487 mL | 2.435 mL | 4.87 mL | 12.1749 mL | |
20 mM | 0.2435 mL | 1.2175 mL | 2.435 mL | 6.0875 mL | |
50 mM | 0.0974 mL | 0.487 mL | 0.974 mL | 2.435 mL | |
100 mM | 0.0487 mL | 0.2435 mL | 0.487 mL | 1.2175 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Hesperin 4430-35-7 Immunology/Inflammation Nrf2 Inhibitor inhibitor inhibit